OmniAb

OMNIAB INC

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

OmniAb Inc

Press Releases

OmniAb to Report First Quarter 2025 Financial Results on May 8

OmniAb Announces Two New Appointments to its Board of Directors

OmniAb to Participate in Five Upcoming Investor Conferences

News

IPOs

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

OmniAb Introduces the xPloration® Partner Access Program

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

Small Cap

Opinion

AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway

OmniAb to Report Second Quarter 2025 Financial Results on August 6

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

OmniAb Announces $30 Million Private Placement

AVAI

CAPR

OABI

RXRX

TECH

TVGN

VACH

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Fortrea Holdings

Harvard Bioscience

ImmunoPrecise Antibodies Ltd. - Common Stock

ImmunoPrecise Antibodies

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

RBC Capital

Benchmark

HC Wainwright & Co.

Truist Securities

Craig-Hallum

Comments

OmniAb

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL